Fulvestrant-(7Alpha-17Beta)-4-Bromo-7-[9-Bromo-Nonyl]-Estra-1,3,5(10)-Triene-3,17-Diol -17 Acetate
CAS No. | : |
Mol F. | : C29H42Br2O3 |
Mol W. | : 598.45 |
Cat No. | : SA11821 |
- Description
- Quick Enquiry / RFQ
Description
Product Name | Fulvestrant-(7Alpha-17Beta)-4-Bromo-7-[9-Bromo-Nonyl]-Estra-1,3,5(10)-Triene-3,17-Diol -17 Acetate |
Synonyms | (7R,8R,9S,13S,14S,17S)-4-bromo-7-(9-bromononyl)-3-hydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-17-yl acetate |
Related API | Fulvestrant |
Category | Impurities |
Order Fulvestrant-(7Alpha-17Beta)-4-Bromo-7-[9-Bromo-Nonyl]-Estra-1,3,5(10)-Triene-3,17-Diol -17 Acetate impurity standard with CAS: and speed up your Fulvestrant project. This product is also known as (7R,8R,9S,13S,14S,17S)-4-bromo-7-(9-bromononyl)-3-hydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-17-yl acetate; and can be used as a working standard or secondary reference standard. Additional internal validation as per respective FDA regulations/guidelines may require. This compound is generally used for Quality Control (QC), Quality Assurance (QA) during commercial production of Fulvestrant and its related formulations. Moreover, (7R,8R,9S,13S,14S,17S)-4-bromo-7-(9-bromononyl)-3-hydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-17-yl acetate is also used in the process of Abbreviated New Drug Application (ANDA) filing to FDA and toxicity study of respective drug formulation.
If you need different pack size / quantity, please contact us or email us at [email protected]